Monteris Medical
Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.
Inclusion Criteria: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Patients with radiographically proven (by gadolinium-enhanced \[Gd-\] MRI) parenchymal brain metastases from histologically confirmed non-central nervous system (CNS) cancer 2. Patients with a "targetable", bi-dimensionally-measurable, intracranial lesion that is considered the first radiographic recurrence after upfront treatment with SRS +/- surgery (craniotomy or LITT). Prior whole brain radiation therapy (WBRT) is permitted provided the target lesion is at f…
Post-op hypofractionated therapy or no radiation therapy
Best medical management with steroid therapy
Minimally invasive technique to necrotize intracranial lesions using the NeuroBlate® System (NBS)